Is Trinity Biotech plc (TRIB) a Loser in the Healthcare Sector?

Trinity Biotech plc (TRIB) is around the bottom of the Healthcare sector according to InvestorsObserver. TRIB received an overall rating of 10, which means that it scores higher than 10% of stocks. Additionally, Trinity Biotech plc scored a 12 in the Healthcare sector, ranking it higher than 12% of stocks in that sector.

TRIB has an Overall Score of 10. Find out what this means to you and get the rest of the rankings on TRIB!

See Full TRIB Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 10 would rank higher than 10 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Trinity Biotech plc Stock Today?

Trinity Biotech plc (TRIB) stock is trading at $2.43 as of 10:34 AM on Tuesday, Sep 14, a drop of -$0.08, or -3.19% from the previous closing price of $2.51. The stock has traded between $2.42 and $2.50 so far today. Volume today is light. So far 44,236 shares have traded compared to average volume of 171,780 shares. Click Here to get the full Stock Report for Trinity Biotech plc stock.